Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ligand Pharmaceuticals Inc (LGND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Dorset Management

David M. Knott

353,041 $25,673 16.2%
2.
Stonepine Capital

Timothy P. Lynch

160,919 $11,702 12.37%
3.
Steelhead PartnersBOND

Michael Johnston

59,956,000 $49,653 -7% 4.87%
4.
Cardinal Capital

Amy Minella

982,049 $71,415 +7% 3.51%
5.
Canyon Capital AdvisorsBOND

Joshua Friedman And Mitchell Julis

60,000,000 $49,708 -8% 1.75%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$87.01 750 Director 67,203 2019-09-03 Filing
$86.18 500 Officer 17,151 2019-09-03 Filing
$90.01 746 Director 66,453 2019-08-05 Filing
$93.59 1,000 Director 49,474 2019-08-02 Filing
$95.98 1,000 Director 26,359 2019-08-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$118.59 11,146 Officer 40,877 2020-06-04 Filing
$110.00 7,225 Officer 153,743 2020-02-27 Filing
$95.84 7,225 Officer 156,229 2020-02-14 Filing
$94.45 4,091 Director 23,600 2019-07-31 Filing
$112.92 2,500 Director 25,542 2019-05-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 18,000,000 $14,906 4.68%
2. 635,758 $46,232 3.94%
3. 246,251 $17,907 3.07%
4. 151,792 $11,038 2.47%
5. 20,034 $1,457 2.21%
News See All